Literature DB >> 32563296

Identifying the best treatment for young people with depression.

Jeffrey R Strawn1, John T Walkup2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32563296      PMCID： PMC8045975          DOI： 10.1016/S2215-0366(20)30236-4

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  10 in total

1.  Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features.

Authors:  Patricia A. Marken; J Stuart Munro
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-12

2.  Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.

Authors:  Xinyu Zhou; Teng Teng; Yuqing Zhang; Cinzia Del Giovane; Toshi A Furukawa; John R Weisz; Xuemei Li; Pim Cuijpers; David Coghill; Yajie Xiang; Sarah E Hetrick; Stefan Leucht; Mengchang Qin; Jürgen Barth; Arun V Ravindran; Lining Yang; John Curry; Li Fan; Susan G Silva; Andrea Cipriani; Peng Xie
Journal:  Lancet Psychiatry       Date:  2020-07       Impact factor: 27.083

Review 3.  Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.

Authors:  Jeffrey R Strawn; Laura Geracioti; Neil Rajdev; Kelly Clemenza; Amir Levine
Journal:  Expert Opin Pharmacother       Date:  2018-07       Impact factor: 3.889

4.  Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysis.

Authors:  Jeffrey A Mills; Jeffrey R Strawn
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-11-01       Impact factor: 8.829

Review 5.  Antidepressant Efficacy for Depression in Children and Adolescents: Industry- and NIMH-Funded Studies.

Authors:  John T Walkup
Journal:  Am J Psychiatry       Date:  2017-03-03       Impact factor: 18.112

6.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

7.  A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

Authors:  G J Emslie; A J Rush; W A Weinberg; R A Kowatch; C W Hughes; T Carmody; J Rintelmann
Journal:  Arch Gen Psychiatry       Date:  1997-11

8.  Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.

Authors:  David A Brent; Graham J Emslie; Greg N Clarke; Joan Asarnow; Anthony Spirito; Louise Ritz; Benedetto Vitiello; Satish Iyengar; Boris Birmaher; Neal D Ryan; Jamie Zelazny; Matthew Onorato; Betsy Kennard; Taryn L Mayes; Lynn L Debar; James T McCracken; Michael Strober; Robert Suddath; Henrietta Leonard; Giovanna Porta; Martin B Keller
Journal:  Am J Psychiatry       Date:  2009-02-17       Impact factor: 18.112

9.  The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.

Authors:  Jeffrey R Strawn; Jeffrey A Mills; Beau A Sauley; Jeffrey A Welge
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-02-08       Impact factor: 8.829

10.  Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial.

Authors:  Ian M Goodyer; Shirley Reynolds; Barbara Barrett; Sarah Byford; Bernadka Dubicka; Jonathan Hill; Fiona Holland; Raphael Kelvin; Nick Midgley; Chris Roberts; Rob Senior; Mary Target; Barry Widmer; Paul Wilkinson; Peter Fonagy
Journal:  Lancet Psychiatry       Date:  2016-12-01       Impact factor: 27.083
  10 in total
  2 in total

1.  Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressants.

Authors:  Arjun P Athreya; Jennifer L Vande Voort; Julia Shekunov; Sandra J Rackley; Jarrod M Leffler; Alastair J McKean; Magdalena Romanowicz; Betsy D Kennard; Graham J Emslie; Taryn Mayes; Madhukar Trivedi; Liewei Wang; Richard M Weinshilboum; William V Bobo; Paul E Croarkin
Journal:  J Child Psychol Psychiatry       Date:  2022-03-15       Impact factor: 8.265

2.  The Impact of Failed Antidepressant Trials on Outcomes in Children and Adolescents with Anxiety and Depression: A Systematic Review and Meta-Analysis.

Authors:  Sarah A Mossman; Jeffrey A Mills; John T Walkup; Jeffrey R Strawn
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-04-21       Impact factor: 3.031
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.